Osphos Injectable

Osphos Injectable


Categories: ,


  • Navicular syndrome is a multifaceted disease and the treatment options are not always clear.
  • When radiographic signs indicative of bony changes associated with navicular syndrome are present, OSPHOS is a clear choice.

What is Osphos?

  • Injectable bisphosphonate solution for the control of clinical signs associated with navicular syndrome
  • OSPHOS inhibits bone resorption by binding to calcium phosphate crystals (inhibiting their formation and dissolution), and by exerting direct cellular effects on osteoclasts.
  • OSPHOS is supplied as 15 mL (900 mg) of clodronate disodium (60 mg/mL) per vial and is ready-to-use (no reconstitution or dilution required).


There are no reviews yet.

Be the first to review “Osphos Injectable”

Your email address will not be published. Required fields are marked *

Open chat
Hello 👋
Can we help you?